Işletim Giderleri Değişiklik Tarih
AbbVie USD 10.52B 258M 2026-09
Agios Pharmaceuticals USD 155.3M 24.53M 2026-06
ALKERMES USD 1.86B 56.17M 2026-09
Amgen USD 5.69B 6B 2026-09
Biogen USD 2.32B 663.6M 2026-09
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Coherus Biosciences USD 51.83M 2.48M 2025-12
Eli Lilly USD 10.52B 496M 2026-06
Exelixis USD 390.27M 10M 2026-09
Genmab DKK 748M 77M 2026-06
Gilead Sciences USD 13.04B 9.09B 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
Glaxosmithkline GBP 6.76B 1.42B 2026-09
Incyte USD 5.64B 4.67B 2026-09
Ionis Pharmaceuticals USD 373M 2.76M 2026-09
J&J USD 18.93B 1.09B 2026-09
Merck USD 10.75B 5.02B 2026-09
Moderna USD 1.18B 223M 2026-09
Neurocrine Biosciences USD 779.7M 40.6M 2026-09
Novartis USD 9.88B 325M 2026-09
Novartis USD 13.19B 3.9B 2026-09
Pfizer USD 89B 3.81B 2026-09
PTC Therapeutics USD 211.54M 15.12M 2026-06
Puma Biotechnology USD 49.26M 3.2M 2024-06
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 10.51B 598M 2026-09
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
Takeda JPY 981.78B 36.71B 2026-09
Teva Pharmaceutical Industries USD 3.18B 733M 2026-09
Ultragenyx Pharmaceutical USD 283M 6M 2026-09
Vertex Pharmaceuticals USD 2.18B 118.2M 2026-09